GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
This Quarter Return
+1.88%
1 Year Return
+15.68%
3 Year Return
+21.54%
5 Year Return
+22.27%
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
(-6.5%)
Cap. Flow
+$1.39M
Cap. Flow
% of AUM
1.22%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
108
New
22
Increased
21
Reduced
7
Closed
24
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$4.12M |
| 2 |
Bank of America
BAC
|
$2.76M |
| 3 |
Aclaris Therapeutics
ACRS
|
$2.58M |
| 4 |
Axogen
AXGN
|
$2.57M |
| 5 |
Hudson Technologies
HDSN
|
$2.08M |
Top Sells
| 1 |
Apple
AAPL
|
$4.91M |
| 2 |
HIMX
Himax Technologies
HIMX
|
$3.7M |
| 3 |
Sarepta Therapeutics
SRPT
|
$2.74M |
| 4 |
CY
Cypress Semiconductor
CY
|
$2.22M |
| 5 |
STMicroelectronics
STM
|
$1.98M |
Sector Composition
| 1 | Healthcare | 28.78% |
| 2 | Consumer Discretionary | 13.79% |
| 3 | Technology | 12.34% |
| 4 | Communication Services | 10.56% |
| 5 | Financials | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $5.8M | 4.62% | 466,015 +8,600 | +2% | +$107K |
|
2
Shake Shack
SHAK
$4.27B
| $5.37M | 4.28% | 150,001 | – | – |
|
|
AERI
3
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.09M | 4.06% | 134,500 | – | – |
|
4
Meta Platforms (Facebook)
META
$1.86T
| $4.88M | 3.89% | 42,400 | – | – |
|
|
ADMS
5
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.33M | 3.45% | 256,031 +31,700 | +14% | +$536K |
|
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.12M | 3.28% | +110,000 | New | +$4.12M |
|
7
JPMorgan Chase
JPM
$829B
| $4.06M | 3.23% | 47,000 +10,625 | +29% | +$917K |
|
8
Amazon
AMZN
$2.44T
| $3.81M | 3.03% | 5,075 | – | – |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $3.63M | 2.9% | 50,000 +2,200 | +5% | +$160K |
|
|
10
Aclaris Therapeutics
ACRS
$209M
| $3.56M | 2.83% | 131,000 +95,000 | +264% | +$2.58M |
|
11
Teekay
TK
$699M
| $3.28M | 2.61% | 408,275 | – | – |
|
|
12
Axogen
AXGN
$743M
| $3.17M | 2.53% | 352,000 +285,000 | +425% | +$2.57M |
|
|
13
Bank of America
BAC
$376B
| $2.76M | 2.2% | +125,000 | New | +$2.76M |
|
14
NetEase
NTES
$86.2B
| $2.75M | 2.19% | 12,775 +1,500 | +13% | +$323K |
|
|
15
Hudson Technologies
HDSN
$444M
| $2.68M | 2.14% | 335,000 +260,000 | +347% | +$2.08M |
|
|
MB
16
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $2.57M | 2.05% | 120,698 | – | – |
|
17
NVIDIA
NVDA
$4.24T
| $1.92M | 1.53% | 18,000 | – | – |
|
|
BFYT
18
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.79M | 1.42% | +100,000 | New | +$1.79M |
|
|
SOHU
19
Sohu.com
SOHU
$483M
| $1.74M | 1.39% | 51,300 +46,300 | +926% | +$1.57M |
|
20
Silicon Motion
SIMO
$2.71B
| $1.7M | 1.35% | +40,000 | New | +$1.7M |
|
|
EVBG
21
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.69M | 1.35% | 91,500 | – | – |
|
|
22
Sarepta Therapeutics
SRPT
$1.78B
| $1.65M | 1.31% | 60,000 -100,000 | -63% | -$2.74M |
|
23
Advanced Energy
AEIS
$5.65B
| $1.64M | 1.31% | +30,000 | New | +$1.64M |
|
|
NORD
24
DELISTED
Nord Anglia Education, Inc.
NORD
| $1.63M | 1.3% | 70,000 +23,200 | +50% | +$541K |
|
|
NXTM
25
DELISTED
NxStage Medical Inc.
NXTM
| $1.58M | 1.26% | 60,250 | – | – |
|